Publicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (35)

2022

  1. Gene Expression Profiles of Visceral and Subcutaneous Adipose Tissues in Children with Overweight or Obesity: The KIDADIPOSEQ Project

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  2. Monocyte-to-Lymphocyte Ratio in Clot Analysis as a Marker of Cardioembolic Stroke Etiology

    Translational Stroke Research, Vol. 13, Núm. 6, pp. 949-958

  3. The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia

    Cancers, Vol. 14, Núm. 6

2021

  1. Engraftment characterization of risk-stratified AML in NSGS mice

    Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

2020

  1. Bone marrow clonogenic myeloid progenitors from NPM1-mutated AML patients do not harbor the NPM1 mutation: Implication for the cell-of-origin of NPM1+ AML

    Genes, Vol. 11, Núm. 1

  2. Factors associated with the number of drugs in darunavir/cobicistat regimens

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214

2019

  1. Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

    Haematologica, Vol. 104, Núm. 2, pp. e54-e58

  2. Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 19, Núm. 1, pp. 45-57

2018

  1. Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex

    Neurologia, Vol. 33, Núm. 3, pp. 141-153

  2. Cost of treating peripheral neuropathic pain with pregabalin or gabapentin at therapeutic doses in routine practice

    Journal of Comparative Effectiveness Research, Vol. 7, Núm. 7, pp. 615-625

  3. Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017

    Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496

2017

  1. Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity

    Journal of Evaluation in Clinical Practice, Vol. 23, Núm. 2, pp. 402-412

  2. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

    Stem Cell Reports, Vol. 8, Núm. 6, pp. 1573-1586

  3. Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya

    Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501

2016

  1. Home Parenteral Nutrition in Spain, 2015. Home and Ambulatory Artificial Nutrition (NADYA) Group report

    Nutricion Hospitalaria, Vol. 33, Núm. 6, pp. 1487-1490

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

  2. Perfil clínico y seguimiento de los pacientes con hepatitis C crónica en hospitales españoles: Estudio disHCovery

    Revista Espanola de Quimioterapia, Vol. 28, Núm. 3, pp. 145-153

2014

  1. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

  2. Nutrición Parenteral Domiciliaria en España 2011 y 2012; informe del grupo de nutrición artificial domiciliaria y ambulatoria NADYA

    Nutricion Hospitalaria, Vol. 29, Núm. 6, pp. 1360-1365

2012

  1. Common health problems management uncertainties in heart failure: A qualitative study

    Farmacia Hospitalaria, Vol. 36, Núm. 6, pp. 498-505